Press Releases

Featured Press Releases

Massachusetts Governor Maura Healey Named BIO’s…

Annual award honors governors for their leadership and commitment to strengthening biotechnology in their state BOSTON (June 17, 2025) – Today, the Biotechnology Innovation Organization (BIO) named Massachusetts Governor Maura Healey…

Learn more

BIO Elects Genentech’s Fritz Bittenbender as New…

Industry veteran takes the helm as Dr. Ted Love concludes two-year term marked by strategic growth and transition BOSTON (June 16, 2025) – Today, the Biotechnology Innovation Organization (BIO) announced that Fritz Bittenbender,…

Learn more

BIO International Convention Opens in Boston,…

The world’s largest biotech gathering unites 20,000+ leaders to accelerate breakthroughs that heal, protect, and nourish humanityBOSTON (June 16, 2025) The BIO International Convention, the world’s largest and most comprehensive event for…

Learn more

GM Crops Increase Environmental Sustainability and Farmer Incomes

June 5, 2017

Washington, D.C. (June 5, 2017) – Over the last twenty years, biotech crops have increased agriculture’s environmental sustainability, while providing significant economic benefits, according to a newly released global impacts study.

BIO Statement on Supreme Court Ruling in Impression Products v. Lexmark International

May 30, 2017

Washington, DC (May 30, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement in response to the Supreme Court’s ruling in Impression Products v. Lexmark International.

POET Founder, Chairman and CEO Jeff Broin to Receive 2017 BIO George Washington Carver Award

May 25, 2017

BIO today announced that POET Founder, Chairman and CEO Jeff Broin will receive the 10th annual George Washington Carver Award for Innovation in Industrial Biotechnology. The award will be presented on Monday July 24, 2017, during a morning plenary…

BIO Applauds Creation of FDA Opioid Policy Steering Committee

May 24, 2017

Washington, DC (May 24, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the announced creation of an Opioid Policy Steering Committee at the Food and Drug…

Astellas Expands Advocacy Engagement with Focused Outreach

May 23, 2017

Astellas recognizes the crucial role that patient groups play in enhancing and extending the lives of patients. Sponsoring events such as the BIO Patient and Health Advocacy Summit to be held on November 3-4 is a way the Astellas…

BIO Statement on President’s Proposed 2018 Budget

May 23, 2017

Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement in response to President Trump’s FY 2018 budget proposal.

Biotech Industry Continues Strong Growth in 2016; San Diego Setting Pace for State, Nation

May 17, 2017

Mayor Faulconer, Industry Leaders Reveal Latest Data, Including Major Economic Benefits of June BIO 2017 Convention

BIO Joins Diverse Coalition Promoting Market-Based Solutions to Address Prescription Drug Costs, Increase Patient Access and Choice

May 17, 2017

Washington, DC (May 17, 2017) – Today, the Biotechnology Innovation Organization (BIO) joins with a diverse coalition of stakeholders in endorsing a set of pro-competition, free-market-oriented solutions to lower healthcare costs while…

BIO Submits Comments to EPA Regulatory Reform Task Force

May 16, 2017

BIO submitted comments to the Environmental Protection Agency’s Regulatory Reform Task Force on Executive Order 13777 “Enforcing the Regulatory Reform Agenda.”

BIO Statement on the Passing of Biotechnology Giant Henri Termeer

May 15, 2017

Termeer was a key architect in the founding of BIO, a mentor to countless entrepreneurs, executives and researchers, and passionate in his pursuit of innovative patient-centric drug development. Washington, DC (May 15, 2017) – Henri…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.